Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melinda L Morgan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Psychiatry|June 18, 2005
Estrogen augmentation of antidepressants in perimenopausal depression: a pilot studyMelinda L Morgan, Ian A Cook, Andrea J Rapkin, et al.
The American Journal of Psychiatry|August 1, 2006
Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depressionAimee M Hunter, Andrew F Leuchter, Melinda L Morgan, et al.
Maturitas|July 13, 2006
Neurophysiologic changes during estrogen augmentation in perimenopausal depressionMelinda L Morgan, Ian A Cook, Andrea J Rapkin, et al.
Journal of Psychiatric Research|July 5, 2005
Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot studyIan A Cook, Andrew F Leuchter, Melinda L Morgan, et al.
Archives of Women'S Mental Health|September 4, 2009
Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal womenMelinda L Morgan, Andrea J Rapkin, Giovanni Biggio, et al.
Neuropsychobiology|July 2, 2005
Influence of age, gender, health status, and depression on quantitative EEGMelinda L Morgan, Elise A Witte, Ian A Cook, et al.
International Journal of Geriatric Psychiatry|July 12, 2002
Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot studyIan A Cook, Melinda L Morgan, Jennifer J Dunkin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 8, 2005
Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placeboAimee M Hunter, Andrew F Leuchter, Melinda L Morgan, et al.
Clinical EEG and Neuroscience|December 3, 2008
Changes in brain function during administration of venlafaxine or placebo to normal subjectsAndrew F Leuchter, Ian A Cook, David J DeBrota, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 11, 2004
Longitudinal progression of subclinical structural brain disease in normal agingIan A Cook, Andrew F Leuchter, Melinda L Morgan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Psychiatry|June 18, 2005
Estrogen augmentation of antidepressants in perimenopausal depression: a pilot studyMelinda L Morgan, Ian A Cook, Andrea J Rapkin, et al.
The American Journal of Psychiatry|August 1, 2006
Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depressionAimee M Hunter, Andrew F Leuchter, Melinda L Morgan, et al.
Maturitas|July 13, 2006
Neurophysiologic changes during estrogen augmentation in perimenopausal depressionMelinda L Morgan, Ian A Cook, Andrea J Rapkin, et al.
Journal of Psychiatric Research|July 5, 2005
Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot studyIan A Cook, Andrew F Leuchter, Melinda L Morgan, et al.
Archives of Women'S Mental Health|September 4, 2009
Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal womenMelinda L Morgan, Andrea J Rapkin, Giovanni Biggio, et al.
Neuropsychobiology|July 2, 2005
Influence of age, gender, health status, and depression on quantitative EEGMelinda L Morgan, Elise A Witte, Ian A Cook, et al.
International Journal of Geriatric Psychiatry|July 12, 2002
Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot studyIan A Cook, Melinda L Morgan, Jennifer J Dunkin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 8, 2005
Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placeboAimee M Hunter, Andrew F Leuchter, Melinda L Morgan, et al.
Clinical EEG and Neuroscience|December 3, 2008
Changes in brain function during administration of venlafaxine or placebo to normal subjectsAndrew F Leuchter, Ian A Cook, David J DeBrota, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 11, 2004
Longitudinal progression of subclinical structural brain disease in normal agingIan A Cook, Andrew F Leuchter, Melinda L Morgan, et al.
Pageof 2